Eli Lilly and Company (FRA:LLY)
875.20
+6.30 (0.73%)
Last updated: Dec 5, 2025, 2:31 PM CET
Eli Lilly and Company Revenue
Eli Lilly and Company had revenue of $17.60B USD in the quarter ending September 30, 2025, with 53.87% growth. This brings the company's revenue in the last twelve months to $59.42B, up 45.41% year-over-year. In the year 2024, Eli Lilly and Company had annual revenue of $45.04B with 32.00% growth.
Revenue (ttm)
$59.42B
Revenue Growth
+45.41%
P/S Ratio
15.35
Revenue / Employee
$1.26M
Employees
47,000
Market Cap
777.61B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 45.04B | 10.92B | 32.00% |
| Dec 31, 2023 | 34.12B | 5.58B | 19.56% |
| Dec 31, 2022 | 28.54B | 223.00M | 0.79% |
| Dec 31, 2021 | 28.32B | 3.78B | 15.40% |
| Dec 31, 2020 | 24.54B | 2.22B | 9.95% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 36.49B |
| Siemens Aktiengesellschaft | 78.91B |
| Allianz SE | 105.02B |
| Deutsche Telekom AG | 121.02B |
| Siemens Energy AG | 39.08B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.10B |
| Rheinmetall AG | 11.00B |
| Deutsche Bank Aktiengesellschaft | 29.86B |
Eli Lilly and Company News
- 1 day ago - Zacks Industry Outlook Highlights Eli Lilly, Johnson & Johnson and Sanofi - Nasdaq
- 1 day ago - With Netflix's 10-for-1 Stock Split Complete, Here Are 3 Growth Stocks to Buy in December That Could Issue Stock Splits in 2026 - The Motley Fool
- 1 day ago - Dow Jones Futures: Small Caps Surge, Eli Lilly Faces Test; 5 Stocks In Buy Zones - Investor's Business Daily
- 1 day ago - Behind the Scenes of Eli Lilly's Latest Options Trends - Benzinga
- 1 day ago - Eli Lilly (LLY): BMO Capital Raises Price Target, Maintains Rating | LLY Stock News - GuruFocus
- 1 day ago - Chinese Biotech Ming Yu Well Positioned For A Strong Hong Kong IPO - Benzinga
- 2 days ago - Eli Lilly And Indiana University Sign $40 Mln Agreement To Expand Clinical Trials In Indiana - Nasdaq
- 2 days ago - FDA Expands Approval For Lilly's Cancer Drug Jaypirca - Nasdaq